GlassScriptPhysician profile
Anna M Garbula
NPI 1720341035
$754.76
in general payments reported to CMS, 2019-2025
15 companies · $43.11 in 2025
The $43.11 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.55 · 2020: $62.66 · 2022: $26.18 · 2023: $243 · 2024: $324 · 2025: $43.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alafair Biosciences, INC. | $177.25 | 2024 | Versawrap |
| Horizon Therapeutics Plc | $66.88 | 2022-2023 | Krystexxa |
| Orthofix Medical, INC. | $66.19 | 2023-2025 | Physio-Stim |
| Organogenesis INC. | $65.99 | 2023 | Puraply |
| Fusion Orthopedics USA, LLC | $64.87 | 2024 | |
| Medtronic, INC. | $62.46 | 2024 | Intellis Adaptivestim |
| Aroa Biosurgery Incorporated | $50.38 | 2023 | |
| Zimmer Biomet Holdings, INC. | $35.28 | 2020 | |
| Acera Surgical, INC. | $34.15 | 2023 | Restrata Wound Matrix |
| Integra Lifesciences Corporation | $27.38 | 2020 | |
| Melinta Therapeutics, LLC | $24.95 | 2023 | Kimyrsa |
| Abbott Laboratories | $22.43 | 2025 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $22.17 | 2019 | |
| Stryker Corporation | $19.49 | 2019 | |
| Misonix INC | $14.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Garbula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.